• +1 513 549 5911 (U.S.)
  • +44 203 318 2846 (U.K.)

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports

Non-Invasive Cancer Diagnostics Market

Non-Invasive Cancer Diagnostics Market By type (Breast Cancer, Blood Cancer, Lung Cancer and Solid Tumors) By Technology (Immunochemistry, Molecular Diagnosis and Clinical Chemistry)- Global Forecast till 2025

  • Published Date : 25 Jun 2018
  • Reports Monitor
  • Category : Medical Devices
  • Pages : N/A

Market Scenario:
Noninvasive diagnostics is a technique of the detection of cancer disease through less incision into body. Early detection of cancer and treatment is very crucial for the long-term survival. It helps in providing faster diagnosis solution, early detection, better condition to the patients, and important assistance to the clinician. This is the minimal pain procedure with accurate diagnose results.

According to data published in 2017 by Genome Biology Article, there are two types of studies being done for non-invasive cancer diagnostics, including general cancer detection with the help of description of circulation tumor DNA and studies of specific type of cancer by development of bio-markers. These studies are helping manufacturers for developing advanced detection kits for cancer.

Rising prevalence of cancer is attributed to propel the growth of non-invasive cancer diagnostic market. Cancer is the major cause of death across the world, affecting economies of several countries.

According to estimation of American Cancer Society, in 2013, approximately 16,60,290 new cases of cancers were diagnosed.

According to the estimation of National Cancer Institute (NIH), the number of cancer incidences were around 439.2 per 100,000 person between 2011 to 2015 and around 15.5 million individuals were cancer survivors in the United States, which is estimated to be 20.3 million individuals in 2026.

According to the estimation of U.S. Breast Cancer Surveillance Consortium (BCSC), the rate of cancer detection were around 25.3 per thousand person in 2005. which increased to 34.7 per thousand person in 2013.

Moreover, governmental and non government organizations are also spreading awareness for different types of cancer as well as conducting several screening programme. Furthermore, there are many key players participating in improving diagnosis rate by conveying the benefits of early detection of cancer. In addition, rising expenditure for further research and development is attributed to boost the market growth.

Regional Analysis:
Geographically, non-invasive cancer diagnostics market can be segmented as North America, Europe, Asia Pacific, and LAMEA. North America is expected to be dominant in the market, followed by Europe, owing to factors including rising prevalence of cancer, increasing demand of noninvasive diagnostics techniques, increasing awareness towards various cancer diseases and the availability of alternative treatments. Moreover, continuous research in oncology segment has led to the positive impact on the market.

Asia-Pacific is predicted to grow in the non-invasive cancer diagnostics market, attributed to factors including developing health-care infrastructure, rising geriatric population, and growing awareness regarding the advantages of early diagnosis of disease. Moreover, advanced techniques in cancer detection is anticipated to propel the market growth. Furthermore, changing lifestyle and increasing consumption of alcohol and tobacco are major factors contributing to increasing cancer burden.  However, high cost of cancer treatment may impede the non-invasive cancer diagnostics market.

Latin America and Middle East & Africa is expected to growing market due to factors such as rising concern regarding cancer across world and huge investment in this region by several leading companies due to large untapped market. This region represents immense opportunity for several global players because of the large unmet needs of cancer patients. In view of all relating factors, non-invasive cancer diagnostics treatment market is growing in this region.

Key Players:
Major global players in the market are: Roche Diagnostics, Quidel, Compugen, DiagnoCure, Immunicon Corporation, Abbott Molecular, GE Healthcare, Affymetrix Inc, Digene Corporation and Precision Therapeutics.

Competitive Intelligence:
A leading genetic testing company, Natera, Inc., launched ctDNA technology based product Sigatera for the detection of cancer disease, in 2017. Similar strategies has been adopted by other industrial key players. Exosome Diagnostics, Inc announced the launch of ExoDx Prostate (IntelliScore) test. The test was designed to evaluate possible risk for prostate cancer with the help of genetic data from urine sample.

Segmentation:
By type:

o Breast Cancer 
o Blood Cancer 
o Lung Cancer 
o Solid Tumors

By Technology
o Immunochemistry
o Molecular Diagnosis  
o Clinical Chemistry

Regions Covered
o North America (U.S and Canada)
o Europe (Germany, France, Italy and Rest of Europe)
o Asia-Pacific (China, Japan, India, South Korea and Rest of Asia-Pacific)
o LAMEA (Brazil, Turkey, Saudi Arabia, South Africa and Rest of LAMEA)


									

	

Related Reports

U.S. Surgical Staplers Market (2018-2023)

U.S. Surgical Staplers Market Surgical stapling is a technological advancement in medical wound closure methods and is often used as an alternative to traditional methods like suturing. The use of s ...read more

North America Surgical Staplers Market (2018-2023)

North America Surgical Staplers Market Surgical stapling is a technological advancement in medical wound closure methods and is often used as an alternative to traditional methods like suturing. The ...read more

Latin America Surgical Staplers Market (2018-2023)

Latin America Surgical Staplers Market Surgical stapling is a technological advancement in medical wound closure methods and is often used as an alternative to traditional methods like suturing. The ...read more

India Surgical Staplers Market (2018-2023)

India Surgical Staplers Market Surgical stapling is a technological advancement in medical wound closure methods and is often used as an alternative to traditional methods like suturing. The India s ...read more

Europe Surgical Staplers Market (2018-2023)

Europe Surgical Staplers Market Surgical stapling is a technological advancement in medical wound closure methods and is often used as a replacement for traditional methods like suturing. The use of ...read more

Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

How To Reach Us

Reach out to our most senior Sales Professional- Jay Matthews
   +1 513 549 5911 (US)
          +44 203 318 2846 (UK)
   sales@reportsmonitor.com

Our Clients

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
--Marketing Manager at a pharma company in Belgium

Enquire Before Buying

Need to ask a quick question before buying? Please fill out this short form:

Our Features

Wide Network of Publishers

Wide Network of Publishers

Access to over 1M+ market research reports

Trusted by the Best

Trusted by the Best

50+ Clients in Fortune 500

Competitive Pricing

Competitive Pricing

Our regular promotional offers and discounts make us the most economic seller of market reports

Safe and Secure

Safe and Secure

Your payment details are protected by us.